Please login to the form below

Not currently logged in
Email:
Password:

Horizon 2020

This page shows the latest Horizon 2020 news and features for those working in and with pharma, biotech and healthcare.

IMI calls for advancements in machine learning and digital clinical trials

IMI calls for advancements in machine learning and digital clinical trials

The funding, which comes from the EU’s Horizon 2020 research and innovative programme, will also go towards a better control of immune-mediated diseases and non-invasive imaging of immune

Latest news

More from news
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    Switzerland only regained full association to Horizon 2020 this year after not implementing EU migrant quotas voted for in a 2014 referendum.

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    The UK is likely to lose access to Horizon 2020 (the EU Research and Innovation programme). ... The UK government has only said that it will cover any loss of funding from Horizon 2020, but it has made no statement regarding wider or future funding.

  • Deal Watch June 2016 Deal Watch June 2016

    The EU has been a significant source of grant funding for the life science sector through initiatives such as the Framework programmes and Horizon 2020.

  • Investing in the future of R&D Investing in the future of R&D

    What is InnovFin. It is a joint initiative launched by the European Investment Bank Group (EIB and EIF) in cooperation with the European Commission under Horizon 2020. ... InnovFin is available across all eligible sectors under Horizon 2020, in EU Member

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • CureVac’s CEO appointed to EC High Level Group CureVac’s CEO appointed to EC High Level Group

    CureVac’ s CEO appointed to EC High Level Group. Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes. ... Dr Hoerr joins a panel of 15 group members who will advise the EC on how to strengthen support for breakthrough,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Understanding the "Big Picture"

    The way forward. Whether you are seeking funding from private investors or through the grant process like Horizon 2020, a strong understanding of the optimal utility for an innovative healthcare solution

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics